The other is an alternative mechanism of activating development and proliferation, which includes activation oncoproteins such as MET, HER2, BRAF or PIK3CA, cellular transformation induction including epithelial to mesenchymal transition (EMT) or transformation from NSCLC to small cell lung cancer (SCLC). The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.